Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1993 1
1995 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
Nolen H 3rd, Fedorak RN, Friend DR. Nolen H 3rd, et al. J Pharm Sci. 1995 Jun;84(6):677-81. doi: 10.1002/jps.2600840603. J Pharm Sci. 1995. PMID: 7562403 Clinical Trial.
Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
Tozer TN, Rigod J, McLeod AD, Gungon R, Hoag MK, Friend DR. Tozer TN, et al. Pharm Res. 1991 Apr;8(4):445-54. doi: 10.1023/a:1015838825437. Pharm Res. 1991. PMID: 1871038
Relative anti-inflammatory effect of oral dexamethasone-beta-D-glucoside and dexamethasone in experimental inflammatory bowel disease in guinea-pigs.
Friend DR, Phillips S, McLeod A, Tozer TN. Friend DR, et al. J Pharm Pharmacol. 1991 May;43(5):353-5. doi: 10.1111/j.2042-7158.1991.tb06703.x. J Pharm Pharmacol. 1991. PMID: 1680179
A novel colon-specific steroid prodrug enhances sodium chloride absorption in rat colitis.
Fedorak RN, Cui N, Friend DR, Madsen KL, Empey LR. Fedorak RN, et al. Am J Physiol. 1995 Aug;269(2 Pt 1):G210-8. doi: 10.1152/ajpgi.1995.269.2.G210. Am J Physiol. 1995. PMID: 7653560
In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
Haeberlin B, Rubas W, Nolen HW 3rd, Friend DR. Haeberlin B, et al. Pharm Res. 1993 Nov;10(11):1553-62. doi: 10.1023/a:1018956232628. Pharm Res. 1993. PMID: 8290467